Condition : Spasticity, Post-Stroke Intervention : Drug: Botulinum toxin type A Sponsor : GlaxoSmithKline Recruiting - verified August 2011

Condition : Spasticity, Post-Stroke Intervention : Drug: Botulinum toxin type A Sponsor : GlaxoSmithKline Recruiting - verified August 2011

Condition : Myositis Intervention : Procedure: Venepuncture Sponsor : Salford Royal NHS Foundation Trust Recruiting - verified May 1999

Condition : Enthesitis Related Arthritis (ERA) Interventions : Biological: adalimumab - blinded; Biological: placebo for adalimumab - blinded; Drug: Adalimumab - open label Sponsor : Abbott Recruiting...

Condition : Enthesitis Related Arthritis (ERA) Interventions : Biological: adalimumab - blinded; Biological: placebo for adalimumab - blinded; Drug: Adalimumab - open label Sponsor : Abbott Recruiting...

Conditions : Acute Tendonitis; Bursitis Intervention : Drug: MRX-7EAT Sponsors : IL Pharma Inc.; MEDRx Co., Ltd. Completed - verified August 2011

Conditions : Acute Tendonitis; Bursitis Intervention : Drug: MRX-7EAT Sponsors : IL Pharma Inc.; MEDRx Co., Ltd. Completed - verified August 2011

Conditions : Muscular Dystrophies; Duchenne Muscular Dystrophy Interventions : Drug: GSK2402968; Drug: matched placebo Sponsor : GlaxoSmithKline Recruiting - verified August 2011

Conditions : Muscular Dystrophies; Duchenne Muscular Dystrophy Interventions : Drug: GSK2402968; Drug: matched placebo Sponsor : GlaxoSmithKline Recruiting - verified August 2011

Conditions : Cerebrovascular Accident; Spasticity, Post-Stroke Interventions : Drug: Botulinum toxin type A; Drug: placebo Sponsor : GlaxoSmithKline Completed - verified July 2011